Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Shedding of infectious SARS-CoV-2 despite vaccination
Kasen K. Riemersma, Luis A. Haddock, Nancy A. Wilson, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 9, pp. e1010876-e1010876
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
Koen B. Pouwels, Emma Pritchard, Philippa C. Matthews, et al.
Nature Medicine (2021) Vol. 27, Iss. 12, pp. 2127-2135
Open Access | Times Cited: 533
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study
Po Ying Chia, Sean Wei Xiang Ong, Calvin J. Chiew, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 4, pp. 612.e1-612.e7
Open Access | Times Cited: 296
Mitigating Covid-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy
Azizul Haque, Anudeep B. Pant
Journal of Autoimmunity (2022) Vol. 127, pp. 102792-102792
Open Access | Times Cited: 164
Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
Piotr Rzymski, Barbara Poniedziałek, Andrzej Fal
Vaccines (2021) Vol. 9, Iss. 11, pp. 1286-1286
Open Access | Times Cited: 148
Delta Variants of SARS-CoV-2 Cause Significantly Increased Vaccine Breakthrough COVID-19 Cases in Houston, Texas
Paul A. Christensen, Randall J. Olsen, Sheng Long, et al.
American Journal Of Pathology (2021) Vol. 192, Iss. 2, pp. 320-331
Open Access | Times Cited: 110
Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?
Bao V. Duong, Puchanee Larpruenrudee, Tianxin Fang, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 8, pp. 4586-4586
Open Access | Times Cited: 91
Mucosal immunity: The missing link in comprehending SARS-CoV-2 infection and transmission
Michael W. Russell, Jiří Městecký
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 77
Natural triterpenoids from licorice potently inhibit SARS-CoV-2 infection
Yi Yang, Junhua Li, Xinyuan Lai, et al.
Journal of Advanced Research (2021) Vol. 36, pp. 201-210
Open Access | Times Cited: 91
SARS-CoV-2 Delta (B.1.617.2) Variant: A Unique T478K Mutation in Receptor Binding Motif (RBM) of Spike Gene
Hyunjhung Jhun, Ho‐Young Park, Yasmin Hisham, et al.
Immune Network (2021) Vol. 21, Iss. 5
Open Access | Times Cited: 61
Asymptomatic screening for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) as an infection prevention measure in healthcare facilities: Challenges and considerations
Thomas R. Talbot, Mary K. Hayden, Deborah S. Yokoe, et al.
Infection Control and Hospital Epidemiology (2022) Vol. 44, Iss. 1, pp. 2-7
Open Access | Times Cited: 42
Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines
Rupsha Fraser, Aurelio Orta‐Resendiz, Alexander Mazein, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 4, pp. 255-267
Open Access | Times Cited: 31
Critical Needs for Integrated Surveillance: Wastewater-Based and Clinical Epidemiology in Evolving Scenarios with Lessons Learned from SARS-CoV-2
Annalaura Carducci, Ileana Federigi, Giulia Lauretani, et al.
Food and Environmental Virology (2024) Vol. 16, Iss. 1, pp. 38-49
Open Access | Times Cited: 8
Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents
Berislav Bošnjak, Ivan Odak, Joana Barros‐Martins, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 47
Transmission from vaccinated individuals in a large SARS-CoV-2 Delta variant outbreak
Katherine J. Siddle, Lydia A. Krasilnikova, Gage K. Moreno, et al.
Cell (2021) Vol. 185, Iss. 3, pp. 485-492.e10
Open Access | Times Cited: 43
SARS-CoV-2—The Role of Natural Immunity: A Narrative Review
Sara Diani, Erika Leonardi, Attilio Cavezzi, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6272-6272
Open Access | Times Cited: 33
Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers
Gregory Joseph, John Barnes, Eduardo Azziz‐Baumgartner, et al.
JAMA (2022) Vol. 328, Iss. 15, pp. 1523-1523
Open Access | Times Cited: 30
Effectiveness of COVID-19 Vaccination on Transmission: A Systematic Review
Anouk Oordt-Speets, Júlia Spinardi, Carlos Mendoza, et al.
COVID (2023) Vol. 3, Iss. 10, pp. 1516-1527
Open Access | Times Cited: 17
Screening and confirmation tests for SARS-CoV-2: benefits and drawbacks
Muhammad Hakimin Shafie, Marie Antony Dass, Hazlam Shamin Ahmad Shaberi, et al.
Beni-Suef University Journal of Basic and Applied Sciences (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 16
Nanobody screening and machine learning guided identification of cross-variant anti-SARS-CoV-2 neutralizing heavy-chain only antibodies
Peter R. McIlroy, Le Thanh Mai Pham, Thomas Sheffield, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 1, pp. e1012903-e1012903
Open Access
Vaccine efficacy of NVX-CoV2373 against SARS-CoV-2 infection in adolescents in the USA: an ancillary study to a phase 3, observer-blinded, randomised, placebo-controlled trial
Meagan E. Deming, Elizabeth R. Brown, Monica A. McArthur, et al.
The Lancet Microbe (2025), pp. 100984-100984
Open Access
COVID-19 clinical presentation, management, and epidemiology: a concise compendium
David P. Maison, Hawi Tasissa, Amelia N. Deitchman, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
Adjuvanted subunit intranasal vaccine reduces SARS-CoV-2 onward transmission in hamsters
Yongjun Sui, Swagata Kar, Bhavna Chawla, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Time-varying effects of COVID-19 vaccination on symptomatic and asymptomatic infections in a prospective university cohort in the USA
Lucy Robinson, Anna Feting, Isamu Isozaki, et al.
BMJ Open (2025) Vol. 15, Iss. 2, pp. e084408-e084408
Open Access
The Lambda variant of SARS-CoV-2 has a better chance than the Delta variant to escape vaccines
Haolin Liu, Pengcheng Wei, Qianqian Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 37
Viral Load in COVID-19 Patients: Implications for Prognosis and Vaccine Efficacy in the Context of Emerging SARS-CoV-2 Variants
Severino Jefferson Ribeiro da Silva, Suelen Cristina de Lima, Ronaldo Celerino da Silva, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top